BD assay that identifies most at-risk COVID-19 patients receives CE mark

BD has announced the CE mark of BD Multitest 6-Color TBNK Reagent with BD Trucount Tubesto help clinicians identify COVID-19 patients at increased relative risk of intubation with mechanical ventilation (IMV) and mortality at hospital admission.

Show CommentsClose Comments

Leave a comment

%d bloggers like this: